{"id":"asaq-winthrop-sanofi-aventis","safety":{"commonSideEffects":[{"rate":"10%","effect":"Nausea"},{"rate":"5%","effect":"Vomiting"},{"rate":"8%","effect":"Diarrhea"},{"rate":"6%","effect":"Abdominal pain"},{"rate":"12%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL3923877","moleculeType":"Small molecule","molecularWeight":"406.48"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Artemisinin is a peroxide-containing endoperoxide compound that exerts its antimalarial activity through the generation of free radicals, which damage the parasite's cell membrane and proteins. Amodiaquine is a 4-aminoquinoline antimalarial drug that works by interfering with the parasite's heme detoxification pathway.","oneSentence":"Artemisinin and Amodiaquine combination","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:54:59.929Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Malaria"}]},"trialDetails":[{"nctId":"NCT01697787","phase":"PHASE4","title":"Amodiaquine-Artesunate & Artemether-Lumefantrine Efficacy in Burkina Faso","status":"COMPLETED","sponsor":"Centre Muraz","startDate":"2012-10","conditions":"Malaria","enrollment":150},{"nctId":"NCT01567423","phase":"NA","title":"Efficacy Study of Amodiaquine-Artesunate and Artemether-Lumefantrine for the Treatment of Uncomplicated Malaria","status":"COMPLETED","sponsor":"Epicentre","startDate":"2008-04","conditions":"Malaria, Falciparum","enrollment":301}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["COARSUCAM 25 mg/67,5 mg","COARSUCAM 50 mg/135 mg","COARSUCAM 100 mg/270 mg"],"phase":"phase_1","status":"active","brandName":"ASAQ Winthrop® Sanofi Aventis","genericName":"ASAQ Winthrop® Sanofi Aventis","companyName":"Epicentre","companyId":"epicentre","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Artemisinin and Amodiaquine combination Used for Malaria.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}